Kenvue Inc. $KVUE Position Cut by Parthenon LLC

Key Points

• Parthenon LLC reduced its holdings in Kenvue Inc. (NYSE:KVUE) by 21.6%, selling 24,400 shares and now owning 88,380 shares valued at $1.85 million.
• Equities analysts have adjusted their price targets for Kenvue, with JPMorgan lowering it from $24.00 to $21.00, while Citigroup reduced theirs from $20.00 to $17.00.
• Kenvue recently reported Q2 earnings of $0.29 EPS, higher than estimates, but its revenue of $3.84 billion fell short of analyst expectations and was down 4.0% year-over-year.

Parthenon LLC trimmed its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 21.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,380 shares of the company's stock after selling 24,400 shares during the quarter. Parthenon LLC's holdings in Kenvue were worth $1,850,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in KVUE. GAMMA Investing LLC grew its holdings in Kenvue by 33.2% in the 1st quarter. GAMMA Investing LLC now owns 24,778 shares of the company's stock worth $594,000 after buying an additional 6,169 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in Kenvue by 2.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 620,052 shares of the company's stock valued at $14,869,000 after purchasing an additional 16,404 shares in the last quarter. Sowell Financial Services LLC boosted its stake in Kenvue by 17.6% during the 1st quarter. Sowell Financial Services LLC now owns 12,867 shares of the company's stock valued at $309,000 after purchasing an additional 1,924 shares in the last quarter. QRG Capital Management Inc. boosted its stake in Kenvue by 54.8% during the 1st quarter. QRG Capital Management Inc. now owns 15,832 shares of the company's stock valued at $380,000 after purchasing an additional 5,607 shares in the last quarter. Finally, Kingswood Wealth Advisors LLC bought a new position in Kenvue during the 1st quarter valued at $413,000. 97.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. JPMorgan Chase & Co. decreased their price target on Kenvue from $24.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday, October 10th. Royal Bank Of Canada decreased their price target on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research note on Friday, August 8th. Citigroup decreased their price target on Kenvue from $20.00 to $17.00 and set a "neutral" rating for the company in a research note on Thursday, October 9th. UBS Group decreased their price target on Kenvue from $23.00 to $17.00 and set a "neutral" rating for the company in a research note on Wednesday, October 8th. Finally, Rothschild & Co Redburn raised Kenvue from a "neutral" rating to a "buy" rating and decreased their price target for the company from $22.50 to $22.00 in a research note on Friday, September 26th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, nine have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Kenvue has an average rating of "Hold" and an average target price of $21.18.

Kenvue Stock Performance

KVUE opened at $15.30 on Friday. The firm has a market cap of $29.37 billion, a PE ratio of 20.68, a P/E/G ratio of 2.20 and a beta of 0.72. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The business has a fifty day simple moving average of $18.54 and a 200-day simple moving average of $21.04. Kenvue Inc. has a fifty-two week low of $14.05 and a fifty-two week high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The company's revenue was down 4.0% compared to the same quarter last year. During the same period last year, the company posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. As a group, equities analysts predict that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $0.83 annualized dividend and a dividend yield of 5.4%. This is a boost from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.